ClinicalTrials.gov
ClinicalTrials.gov Menu

Protecting the 'Hood Against Tobacco

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00187603
Recruitment Status : Completed
First Posted : September 16, 2005
Last Update Posted : May 8, 2008
Sponsor:
Collaborator:
Tobacco Related Disease Research Program
Information provided by:
University of California, San Francisco

Brief Summary:

Among all racial/ethnic groups, African Americans have the greatest risk of becoming ill or dying from tobacco-related diseases. Because of this disproportionate disease burden, it is particularly urgent that researchers focusing on tobacco control partner with African American communities. Intervention strategies which hold the tobacco industry accountable for its behavior are effective in changing views of tobacco use. In earlier work, the investigators found that information from internal tobacco industry documents, when shown to African American smokers, stimulated reflection about quitting and interest in disseminating information about industry targeting behaviors to others. However, to date there have been no attempts to utilize the information in industry documents as part of a smoking cessation intervention. In this project, the investigators will test whether a community co-developed, tailored quit-smoking program featuring exposures to African American-specific tobacco industry documents and media exercises in addition to proven individual quitting strategies can increase the number of people who quit smoking at six months and one year, as compared with usual care.

The specific aims of the project are to:

  1. test, using statistics, how well an innovative community-based, culturally tailored quit-smoking program for African Americans works at 6 and 12 months;
  2. test selected variables for how well they predict who will return to smoking;
  3. use interviews to identify additional individual and/or community factors associated with successful quitting or relapse; and
  4. collect information to evaluate the overall effectiveness of the CARA project collaborative efforts in developing and sustaining the project over time, enhancing community awareness of tobacco issues, and creation or enhancement of community tobacco control resources.

Condition or disease Intervention/treatment Phase
Smoking Behavioral: tobacco cessation program Not Applicable

Detailed Description:

Among all racial/ethnic groups, African Americans have the greatest risk of becoming ill or dying from tobacco-related diseases. Because of this disproportionate disease burden, it is particularly urgent that researchers focusing on tobacco control partner with African American communities. Intervention strategies which hold the tobacco industry accountable for its behavior are effective in changing views of tobacco use. In earlier work, we found that information from internal tobacco industry documents, when shown to African American smokers, stimulated reflection about quitting and interest in disseminating information about industry targeting behaviors to others. However, to date there have been no attempts to utilize the information in industry documents as part of a smoking cessation intervention. In this project, we will test whether a community co-developed, tailored quit-smoking program featuring exposures to African American-specific tobacco industry documents and media exercises in addition to proven individual quitting strategies can increase the number of people who quit smoking at six months and one year, as compared with usual care.

The specific aims of the project are to:

  1. test, using statistics, how well an innovative community-based, culturally tailored quit-smoking program for African Americans works at 6 and 12 months;
  2. test selected variables for how well they predict who will return to smoking;
  3. use interviews to identify additional individual and/or community factors associated with successful quitting or relapse; and
  4. collect information to evaluate the overall effectiveness of the CARA project collaborative efforts in developing and sustaining the project over time, enhancing community awareness of tobacco issues, and creation or enhancement of community tobacco control resources.

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 270 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Protecting the 'Hood Against Tobacco: Cessation Project
Study Start Date : July 2003
Actual Primary Completion Date : February 2007
Actual Study Completion Date : June 2007

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Smoking




Primary Outcome Measures :
  1. Smoking cessation (cotinine validation) [ Time Frame: at 6 and 12 months ]

Secondary Outcome Measures :
  1. Qualitative interviews


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   21 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • African American adults who have used tobacco in the last month

Exclusion Criteria:

  • Unable to read or speak English
  • Dependence on other substances (except for marijuana)
  • Disabling health conditions that would prevent participation

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00187603


Locations
United States, California
University of California San Francisco
San Francisco, California, United States, 94143
Sponsors and Collaborators
University of California, San Francisco
Tobacco Related Disease Research Program
Investigators
Principal Investigator: Ruth E Malone, RN, PhD Associate Professor UCSF

Responsible Party: Ruth Malone, Professor, University of California, San Francisco
ClinicalTrials.gov Identifier: NCT00187603     History of Changes
Other Study ID Numbers: 12AT-1700
First Posted: September 16, 2005    Key Record Dates
Last Update Posted: May 8, 2008
Last Verified: August 2005

Keywords provided by University of California, San Francisco:
tobacco
cessation
smoking
smoking cessation